|
 |
Parkview Center is designed to meet the changing needs of oncology patients by providing a comfortable, homelike setting for chemotherapy treatments, radiation treatments, blood transfusions and diagnostic procedures. Located in Tuscora Park, Parkview Center is staffed by hematology and oncology specialists who administer the most advanced diagnostic procedures and treatment options. Call (330) 615-4126. Keeping Our Promise to the Community In early 2006, construction began on Summa Barberton Hospital’s 22,000 square foot comprehensive cancer center. “This is very exciting for us. It is our first external expansion since the community overwhelmingly approved our purchase of a portion of Tuscora Park,” said Jim Stonkus, vice president of business development. “As good stewards of this land we plan to keep our promise to the people of Barberton and provide our communities a state-of-the-art cancer center that rivals any other center in this region. Included in Parkview Center is medical oncology, radiation oncology, women’s care services like mammography, outpatient chemotherapy and physician offices. According to Syamala Ahmad, M.D., the center’s new radiation oncologist, “The addition of radiation oncology to Summa Barberton Hospital is significant. Patients will no longer have to travel to other institutions to receive radiation treatments. From a physician’s perspective this is very exciting because all of the physicians associated with the cancer program at Summa Barberton Hospital are able to offer our input into the way the center is being designed and run and what components should be included.” Dr. Sprance Appointed Medical Director of Comprehensive Breast Care Program Lee Anne Sprance, M.D., FACS has been named Medical Director of the Comprehensive Breast Care Program at Summa Barberton Hospital. Dr. Sprance is a board certified surgeon with 15 years of surgical experience. She specializes in the diagnosis and treatment of diseases of the breast. She is also experienced in advanced and minimally invasive surgical procedures such as Stereotactic Mammotome Breast Biopsies, Sentinel Lymph Node Dissection and Mammosite catheter replacement. Dr. Sprance has been instrumental in the development and continued advancement of the breast cancer portion of the cancer program. According to Dr. Sprance anyone with an abnormal mammogram or ultrasound of the breast or anyone with a breast lump is a candidate for evaluation by a breast surgeon. Ultimately, one in every six women in the United States will develop breast cancer. It is the most commonly diagnosed cancer in the United States and worldwide (excluding skin cancer). Recent American Cancer Society statistics for Ohio show that in our state, one in every six women will eventually develop the disease. Clinical Research/Clinical Trials Program As part of Summa Health System, Summa Barberton Hospital now has the ability to participate in over seventy clinical trials. These trials involve several types of cancer and cancer sites: breast, colon, head and neck, lung, leukemia and metastases to bone. Some studies involve radiation therapy and/or chemotherapy or other medications. These studies are sponsored by nationally recognized groups including the National Institutes of Health. Participation in a clinical trial is totally voluntary and prospective participants must meet eligibility criteria and be recommended for a trial by their medical oncologist. For more information, contact the Clinical Trials office at 330-615-4132. |
||||||||
| 155 Fifth Street NE - Barberton, Ohio 44203 - 330-615-3000 | |||||||||